Risky Pick Update - TOS
Because I have already recommended this stock in the past , I won't go through the usual company description. TSO3 has released a bought deal financing raising $ 16 million dollars at a set price of $1.60 per share today, causing the share price to pull back to a great entry price. This financing will allow TOS to continue with operations and focus on new product initiatives in the coming year. TSO3 has also achieved two important milestones since December of last year such as a much anticipated global channel partnership with 3M and the approval of their STERIZONE sterilizer from Health Canada. I believe TOS is well positioned to continue to perform welll in the months to come. I curently rate TOS as a BUY at these levels. As always, do your own DD and make sure TOS is right for you. Have a great trading day.